Get started
Author

Hongyan Li

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification
2019 · Michael T. Parsons, Emma Tudini, et al. · Human Mutation · 145
PDF
Large-scale genome sequencing redefines the genetic footprints of high-altitude adaptation in Tibetans
2023 · Wangshan Zheng, Yaoxi He, et al. · Genome biology · 79
PDF
Double‐Neutral Genes, Sa‐n and Sb‐n, for Pollen Fertility in Rice to Overcome Indica × Japonica Hybrid Sterility
2013 · Muhammad Qasim Shahid, Feng‐Yi Chen, et al. · Crop Science · 36
Infection‐related mortality in Hispanic and non‐Hispanic children with cancer
2017 · Rochelle R. Smits‐Seemann, Jacob Pettit, et al. · Pediatric Blood & Cancer · 19
Identification of platelet-related subtypes and diagnostic markers in pediatric Crohn’s disease based on WGCNA and machine learning
2024 · Dadong Tang, Yingtao Huang, et al. · Frontiers in Immunology · 10
Statewide Treatment Center Referral Patterns for Adolescent and Young Adult Patients with Cancer in Utah
2018 · Holly Spraker-Perlman, Rochelle R. Smits-Seeman, et al. · Journal of Adolescent and Young Adult Oncology · 8
A proposed Lawsonella species with distinct functional features from L. clevelandensis revealed by metagenomics
2025 · Huabing Zhao, Zhaoying Han, et al. · Genomics · 6
Tumorigenesis Driven by BRAFV600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and Migration
2025 · Sunyana Gadal, Jacob A. Boyer, et al. · Cancer Research · 6
Dysfunction of PDE4DIP contributes to LVNC development by regulating cell polarity, skeleton, and energy metabolism via Rho-ROCK pathway
2025 · Wuxia Gu, Hongyan Li, et al. · Genes & Diseases · 3
[Deletion and mutation analysis to FOXL2 in blepharophimosis-ptosis-epicanthus inversus syndrome].
2010 · Zhong-min Zhou, De-sheng Liang, et al. · PubMed · 1
Figure S6 from A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies
2026 · Filemon S. Dela Cruz, Daoqi You, et al.
Figure S10 from A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies
2026 · Filemon S. Dela Cruz, Daoqi You, et al.
Table S3 from A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies
2026 · Filemon S. Dela Cruz, Daoqi You, et al.
Table S1 from A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies
2026 · Filemon S. Dela Cruz, Daoqi You, et al.
Figure S11 from A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies
2026 · Filemon S. Dela Cruz, Daoqi You, et al.
Figure S7 from A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies
2026 · Filemon S. Dela Cruz, Daoqi You, et al.
Figure S5 from A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies
2026 · Filemon S. Dela Cruz, Daoqi You, et al.
Data from A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies
2026 · Filemon S. Dela Cruz, Daoqi You, et al.
Figure S8 from A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies
2026 · Filemon S. Dela Cruz, Daoqi You, et al.
Figure S2 from A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies
2026 · Filemon S. Dela Cruz, Daoqi You, et al.
Figure S4 from A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies
2026 · Filemon S. Dela Cruz, Daoqi You, et al.
Figure S9 from A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies
2026 · Filemon S. Dela Cruz, Daoqi You, et al.
Table S2 from A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies
2026 · Filemon S. Dela Cruz, Daoqi You, et al.
Table S4 from A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies
2026 · Filemon S. Dela Cruz, Daoqi You, et al.
Figure S3 from A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies
2026 · Filemon S. Dela Cruz, Daoqi You, et al.
Works count: 34
Citation count: 313
H-index: 6
I10-index: 5
Year
Topic
Type